SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-085450
Filing Date
2019-03-25
Accepted
2019-03-25 17:25:02
Documents
4
Effectiveness Date
2019-03-25

Document Format Files

Seq Description Document Type Size
1 S-8 d704815ds8.htm S-8 85577
2 EX-5.1 d704815dex51.htm EX-5.1 8756
3 EX-23.1 d704815dex231.htm EX-23.1 1357
4 GRAPHIC g704815g0320173304919.jpg GRAPHIC 2549
  Complete submission text file 0001193125-19-085450.txt   100495
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-230499 | Film No.: 19703493
SIC: 2836 Biological Products, (No Diagnostic Substances)